Literature DB >> 28621882

Exercise Capacity and Functional Performance in Heart Failure Patients Supported by a Left Ventricular Assist Device at Discharge From Inpatient Rehabilitation.

Thomas Schmidt1,2, Birna Bjarnason-Wehrens2, Petra Bartsch1, Ezin Deniz3, Jan Schmitto3, Sebastian Schulte-Eistrup4, Detlev Willemsen1, Nils Reiss1.   

Abstract

Adequate physical and functional performance is an important prerequisite for renewed participation and integration in self-determined private and (where appropriate) professional lives following left ventricular assist device (LVAD) implantation. During cardiac rehabilitation (CR), individually adapted exercise programs aim to increase exercise capacity and functional performance. A retrospective analysis of cardiopulmonary exercise capacity and functional performance in LVAD patients at discharge from a cardiac rehabilitation program was conducted. The results from 68 LVAD patients (59 males, 9 females; 55.9 ± 11.7 years; 47 HVAD, 2 MVAD, 15 HeartMate II, 4 HeartMate 3, and 4 different implanting centers) were included in the analysis. Exercise capacity was assessed using a cardiopulmonary exercise test on a bicycle ergometer (ramp protocol; 10 W/min). The 6-min walk test was used to determine functional performance. At discharge from CR (53 ± 17 days after implantation), the mean peak work load achieved was 62.2 ± 19.3 W (38% of predicted values) or 0.79 ± 0.25 W/kg body weight. The mean cardiopulmonary exercise capacity (relative peak oxygen uptake) was 10.6 ± 5.3 mL/kg/min (37% of predicted values). The 6-min walk distance improved significantly during CR (325 ± 106 to 405 ± 77 m; P < 0.01). No adverse events were documented during CR. The results show that, even following LVAD implantation, cardiopulmonary exercise capacity remains considerably restricted. In contrast, functional performance, measured by the 6-min walk distance, reaches an acceptable level. Light everyday tasks seem to be realistically surmountable for patients, making discharge from inpatient rehabilitation possible. Long-term monitoring is required in order to evaluate the situation and how it develops further.
© 2017 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.

Entities:  

Keywords:  -Cardiac rehabilitation; -Exercise capacity; -Functional performance; -Left ventricular assist device; Heart failure

Mesh:

Year:  2017        PMID: 28621882     DOI: 10.1111/aor.12936

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  5 in total

Review 1.  Approaches to improving exercise capacity in patients with left ventricular assist devices: an area requiring further investigation.

Authors:  Richard Severin; Ahmad Sabbahi; Cemal Ozemek; Shane Phillips; Ross Arena
Journal:  Expert Rev Med Devices       Date:  2019-09-06       Impact factor: 3.166

2.  Using Physical Function to Predict Hospital Readmission within 1 Year in Patients with Heart Failure.

Authors:  Hiroaki Teramatsu; Junichiro Shiraishi; Yasuyuki Matsushima; Masaru Araki; Tetsuya Okazaki; Satoru Saeki
Journal:  Prog Rehabil Med       Date:  2019-10-19

3.  Feasibility of inpatient cardiac rehabilitation after percutaneous mitral valve reconstruction using clipping procedures: a retrospective analysis.

Authors:  Thomas Schmidt; Marek Kowalski; Birna Bjarnason-Wehrens; Frank Ritter; Gerold Mönnig; Nils Reiss
Journal:  BMC Sports Sci Med Rehabil       Date:  2022-07-05

Review 4.  Effects of pump speed changes on exercise capacity in patients supported with a left ventricular assist device-an overview.

Authors:  Thomas Schmidt; Birna Bjarnason-Wehrens; Sebastian Schulte-Eistrup; Nils Reiss
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 5.  Cardiac Rehabilitation in German Speaking Countries of Europe-Evidence-Based Guidelines from Germany, Austria and Switzerland LLKardReha-DACH-Part 1.

Authors:  Bernhard Rauch; Annett Salzwedel; Birna Bjarnason-Wehrens; Christian Albus; Karin Meng; Jean-Paul Schmid; Werner Benzer; Matthes Hackbusch; Katrin Jensen; Bernhard Schwaab; Johann Altenberger; Nicola Benjamin; Kurt Bestehorn; Christa Bongarth; Gesine Dörr; Sarah Eichler; Hans-Peter Einwang; Johannes Falk; Johannes Glatz; Stephan Gielen; Maurizio Grilli; Ekkehard Grünig; Manju Guha; Matthias Hermann; Eike Hoberg; Stefan Höfer; Harald Kaemmerer; Karl-Heinz Ladwig; Wolfgang Mayer-Berger; Maria-Inti Metzendorf; Roland Nebel; Rhoia Clara Neidenbach; Josef Niebauer; Uwe Nixdorff; Renate Oberhoffer; Rona Reibis; Nils Reiss; Daniel Saure; Axel Schlitt; Heinz Völler; Roland von Känel; Susanne Weinbrenner; Ronja Westphal
Journal:  J Clin Med       Date:  2021-05-19       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.